Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk

Name: Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk
Published: 2026
License: Public Domain

Shenyang Northern Hospital · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

acute coronary syndrome (acs), high bleeding risk(hbr), coronary artery disease (cad), dual antiplatelet therapy (dapt), high bleeding risk (hbr), percutaneous coronary intervention (pci), quality control indicators, coronary revascularization, real-world research, bleeding events, ischemic events, post-pci prognosis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 840737
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.